Ruthenium(II)-arene complexes with dibenzoylmethane induce apoptotic cell death in multiple myeloma cell lines

Ruthenium(II)–Arene RAPTA Type Complexes Contai Bisdemethoxycurcumin Display Potent and Selective An Organometallics 33, 3709-3715 DOI: 10.1021/om500317b Citation Report Citation Report # Article IF Citations 3 In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer. Journal of Medicinal Chemistry, 2014, 57, 9995-10012. 5.6 105 4 Hydrogen Bonding and Anticancer Properties of Water―Soluble Chiral <i>p</i>―Cymene Ru^II Compounds with Amino―Oxime Ligands. European Journal of Inorganic Chemistry, 2015, 2015, 2295-2307. 1.8 34 5 Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes. Molecules, 2015, 20, 17244-17274. 4.2 83 6 Water-Soluble Ruthenium(II) Complexes with Chiral 4-(2,3-Dihydroxypropyl)-formamide Oxoaporphine (FOA): In Vitro and in Vivo Anticancer Activity by Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Induction of Tumor Cell Apoptosis. Journal of Medicinal Chemistry, 2015, 58, 4771-4789. 5.6 115 7 Metal Complexes of Curcumin for Cellular Imaging, Targeting, and Photoinduced Anticancer Activity. Accounts of Chemical Research, 2015, 48, 2075-2083. 17.0 288 8 Metal complexes of curcumin – synthetic strategies, structures and medicinal applications. Chemical Society Reviews, 2015, 44, 4986-5002. 37.7 395 9 Discovery of a dual-targeting organometallic ruthenium complex with high activity inducing early stage apoptosis of cancer cells. Metallomics, 2015, 7, 1573-1583. 2.6 37 10 Organometallic rhodium(<scp>iii</scp>) and iridium(<scp>iii</scp>) cyclopentadienyl complexes with curcumin and bisdemethoxycurcumin co-ligands. Dalton Transactions, 2015, 44, 20523-20531. 3.0 61 11 Remarkable Selectivity and Photo―Cytotoxicity of an Oxidovanadium(IV) Complex of Curcumin in Visible Light. European Journal of Inorganic Chemistry, 2015, 2015, 447-457. 1.8 32 12 Bis(alkynyl) PTA and DAPTA complexes of Pt(II) and Pd(II). Polyhedron, 2015, 87, 55-62. 2.4 9 13 Systematical investigation of binding interaction between novel ruthenium(II) arene complex with curcumin analogs and ctDNA. Luminescence, 2016, 31, 1384-1394. 2.9 30 14 Interactions of the “piano―stool― [ruthenium(II)(η⁶―arene)(quinolone)Cl]⁺complexes with water; DFT computational study. Journal of Computational Chemistry, 2016, 37, 1766-1780. 4.8 3 16 In vitro interaction investigation between three Ru(<scp>ii</scp>) arene complexes and human serum albumin: structural influences. RSC Advances, 2016, 6, 47043-47054. 4.4 24 17 Synthesis and in vitro Toxicity of <scp>d</scp>―Glucose and <scp>d</scp>―Fructose Conjugated Curcumin–Ruthenium Complexes. European Journal of Inorganic Chemistry, 2016, 2016, 5197-5204. 1.8 18 18 Arene ruthenium(<scp>ii</scp>) complexes with chalcone, aminoantipyrine and aminopyrimidine based ligands: synthesis, structure and preliminary evaluation of anti-leukemia activity. RSC Advances, 2016, 6, 90982-90992. 4.4 32 19 Ruthenium(II) p-cymene complexes of naphthoquinone derivatives as antitumor agents: A structure−activity relationship study. Journal of Organometallic Chemistry, 2016, 822, 211-220. 2.1 27 20 Neutral 1,3,5―Triaza―7―phosphaadamantane―Ruthenium(II) Complexes as Precursors for the Preparation of 1.8 Highly Water―Soluble Derivatives. European Journal of Inorganic Chemistry, 2016, 2016, 2850-2860. 17 21 Synthesis, Structure, and Anticancer Activity of Arene–Ruthenium(II) Complexes with Acylpyrazolones Bearing Aliphatic Groups in the Acyl Moiety. Inorganic Chemistry, 2016, 55, 11770-11781. 65 2 4.6 Citation Report # Article IF Citations 22 From Sunscreen to Anticancer Agent: Ruthenium(II) Arene Avobenzone Complexes Display Potent Anticancer Activity. Organometallics, 2016, 35, 3734-3742. 2.9 42 23 Fine tuning through valence bond tautomerization of ancillary ligands in ruthenium(<scp>ii</scp>) arene complexes for better anticancer activity and enzyme inhibition properties. Dalton Transactions, 2016, 45, 19277-19289. 3.0 12 24 Photorelease and Cellular Delivery of Mitocurcumin from Its Cytotoxic Cobalt(III) Complex in Visible Light. Inorganic Chemistry, 2016, 55, 6027-6035. 4.6 76 25 In vitro Cytotoxicity of Half-Sandwich Platinum Group Metal Complexes of a Cationic Alkylated Phosphaadamantane Ligand. European Journal of Inorganic Chemistry, 2016, 2016, 1267-1273. 1.8 17 26 Reduction Process of Tetraplatin in the Presence of Deoxyguanosine Monophosphate (dGMP): A Computational DFT Study. Chemistry - A European Journal, 2016, 22, 1037-1047. 3.4 12 27 Metal-based drugs that break the rules. Dalton Transactions, 2016, 45, 3201-3209. 3.0 290 28 (η6-Arene)ruthenium complexes with P-coordinated phosphinoferrocene amides bearing extended polar substituents at the amide nitrogen: Synthesis, characterization and cytotoxicity. Journal of Organometallic Chemistry, 2016, 802, 21-26. 2.1 20 29 Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties. Journal of Inorganic Biochemistry, 2016, 160, 180-188. 3.0 26 30 Multispectroscopic Investigation of the Interaction Between two Ruthenium(II) Arene Complexes of Curcumin Analogs and Human Serum Albumin. Biological Trace Element Research, 2015, 169, 189-203. 3.0 21 31 Metal complexes of curcumin and curcumin derivatives for molecular imaging and anticancer therapy. Coordination Chemistry Reviews, 2016, 307, 32-41. 23.1 118 32 The development of RAPTA compounds for the treatment of tumors. Coordination Chemistry Reviews, 2016, 306, 86-114. 23.1 442 33 Ruthenium(II)-arene complexes with dibenzoylmethane induce apoptotic cell death in multiple myeloma cell lines. Inorganica Chimica Acta, 2017, 454, 139-148. 2.8 30 34 Lipid-based carriers for controlled delivery of nitric oxide. Expert Opinion on Drug Delivery, 2017, 14, 1341-1353. 5.0 36 35 Synthesis, Structures, and CO Release Capacity of a Family of Water-Soluble PhotoCORMs: Assessment of the Biocompatibility and Their Phototoxicity toward Human Breast Cancer Cells. Inorganic Chemistry, 2017, 56, 1534-1545. 4.6 93 36 Synthesis, characterization, cytotoxic activity of half-sandwich rhodium(III), and iridium(III) complexes with curcuminoids. Journal of Organometallic Chemistry, 2017, 833, 54-60. 2.1 21 37 (Pentamethylcyclopentadienato)rhodium Complexes for Delivery of the Curcumin Anticancer Drug. European Journal of Inorganic Chemistry, 2017, 2017, 1812-1823. 1.8 19 38 Side Reactions with an Equilibrium Constraint: Detailed Mechanism of the Substitution Reaction of Tetraplatin with dGMP as a Starting Step of the Platinum(IV) Reduction Process. Journal of Physical Chemistry B, 2017, 121, 4400-4413. 2.7 4 39 Dicationic Ruthenium(II)–Arene–Curcumin Complexes Containing Methylated 1,3,5―Triaza―7―phosphaadamantane: Synthesis, Structure, and Cytotoxicity. European Journal of Inorganic Chemistry, 2017, 2017, 2905-2910. 1.8 24 3 Citation Report # Article 40 Ruthenium Anticancer Agents—From Cisplatin Analogues to Rational Drug Design. , 0, , 1-21. 41 A ruthenium(II)-trithiacyclononane curcuminate complex: Synthesis, characterization, DNA-interaction, and cytotoxic activity. Journal of Coordination Chemistry, 2017, 70, 2393-2408. 2.6 5 42 Synthesis and biological studies of ruthenium, rhodium and iridium metal complexes with pyrazole-based ligands displaying unpredicted bonding modes. Inorganica Chimica Acta, 2017, 462, 223-235. 2.8 15 43 New highly cytotoxic organic and organometallic bexarotene derivatives. Journal of Organometallic Chemistry, 2017, 839, 91-97. 2.1 16 44 β―Diketones as Scaffolds for Anticancer Drug Design – From Organic Building Blocks to Natural Products and Metallodrug Components. European Journal of Inorganic Chemistry, 2017, 2017, 1655-1666. 1.8 78 45 Synthesis, characterization and anticancer activity of a series of curcuminoids and their half―sandwich ruthenium(II) complexes. Applied Organometallic Chemistry, 2017, 31, . 3.8 8 46 Aminophosphine ligands as a privileged platform for development of antitumoral ruthenium(<scp>ii</scp>) arene complexes. Dalton Transactions, 2017, 46, 16113-16125. 3.0 31 47 Curcumin “Drug― Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity. Inorganic Chemistry, 2017, 56, 12457-12468. 4.6 68 48 Cytotoxic Half-Sandwich Rh(III) and Ir(III) β-Diketonates. Inorganic Chemistry, 2017, 56, 13600-13612. 4.6 42 49 Comparative investigation of interactions between two ruthenium(II) arene PTA type complexes with curcuminoid ligands and human serum albumin. Journal of Organometallic Chemistry, 2017, 853, 81-92. 2.1 13 50 Half-sandwich d6 metal complexes with bis(pyridine carboxamide)benzene ligand: Synthesis and spectral analysis. Journal of Molecular Structure, 2017, 1149, 162-170. 4.1 10 51 Curcumin and Its Derivatives – Isolation, Synthesis, and Applications. , 2017, , 145-174. 4 Trends and Perspectives of Ruthenium Anticancer Compounds (Non―) Tj ETQq0 0 0 rgBT /Overlock 10 Tf 50 267 Td ( <scp>PDT< 2 53 The development of anticancer ruthenium(<scp>ii</scp>) complexes: from single molecule compounds to nanomaterials. Chemical Society Reviews, 2017, 46, 5771-5804. 37.7 971 54 Arene–Ruthenium(II) Complexes with Bioactive <i>ortho</i>―Hydroxydibenzoylmethane Ligands: Synthesis, Structure, and Cytotoxicity. European Journal of Inorganic Chemistry, 2017, 2017, 1800-1806. 1.8 25 55 Organoruthenium(II)-Arene Complexes. , 2017, , 119-146. 5 56 Plant―Based Natural Products. , 2017, , . 6 57 Synthesis, characterization and cytotoxicity of arene–ruthenium(<scp>ii</scp>) complexes with acylpyrazolones functionalized with aromatic groups in the acyl moiety. Dalton Transactions, 2018, 47, 868-878. 52 4 IF Citations 3 3.0 30 Citation Report # Article IF Citations 58 Making organoruthenium complexes of 8-hydroxyquinolines more hydrophilic: impact of a novel <scp>l</scp>-phenylalanine-derived arene ligand on the biological activity. Dalton Transactions, 2018, 47, 2192-2201. 3.0 40 59 Synthesis, structural characterisation and antiproliferative activity of a new fluorescent 4-amino-1,8-naphthalimide Tröger's base–Ru(<scp>ii</scp>)–curcumin organometallic conjugate. Chemical Communications, 2018, 54, 4120-4123. 3.4 42 60 Evaluation of Anticancer Activity of Water―Soluble Curcumin through the Induction of Apoptosis by p53 and p21 Modulation. ChemistrySelect, 2018, 3, 2976-2981. 1.7 7 61 Photonics in Drug Delivery. , 2018, , 131-151. 62 Isomeric ruthenium(II) complexes for cancer therapy and cellular imaging. Inorganica Chimica Acta, 2018, 469, 593-599. 2.8 6 63 RAPTA complexes containing N―substituted Tetrazole scaffolds: Synthesis, characterization and Antiproliferative activity. Applied Organometallic Chemistry, 2018, 32, e4179. 3.8 10 64 Synthesis, characterization and ROS-mediated antitumor effects of palladium(II) complexes of curcuminoids. European Journal of Medicinal Chemistry, 2018, 144, 662-671. 5.3 41 65 Organometallics in Cancer Treatment—Non-conventional Structures and Modes of Action. , 2018, , . 66 Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands. Inorganic Chemistry, 2018, 57, 14786-14797. 4.6 38 67 Versatile coordination of acetazolamide to ruthenium(<scp>ii</scp>) <i>p</i>-cymene complexes and preliminary cytotoxicity studies. Dalton Transactions, 2018, 47, 9367-9384. 3.0 25 68 Influence of Functionalized η⁶―Arene Rings on Ruthenium(II) Curcuminoids Complexes. ChemistrySelect, 2018, 3, 6696-6700. 1.7 10 69 A Bioactive <scp>l</scp>-Phenylalanine-Derived Arene in Multitargeted Organoruthenium Compounds: Impact on the Antiproliferative Activity and Mode of Action. Inorganic Chemistry, 2018, 57, 8521-8529. 4.6 32 70 Composite Materials Based on (Cymene)Ru(II) Curcumin Additives Loaded on Porous Carbon Adsorbents from Agricultural Residues Display Efficient Antibacterial Activity. ACS Applied Bio Materials, 2018, 1, 153-159. 4.7 6 71 Half―Sandwich Metal Complexes with β―Diketone―Like Ligands and Their Anticancer Activity. European Journal of Inorganic Chemistry, 2018, 2018, 3521-3536. 1.8 35 72 The Progresses in curcuminoids-based Metal Complexes: Especially in Cancer Therapy. Future Medicinal Chemistry, 2019, 11, 1035-1056. 2.3 15 73 Novel osmium(<scp>ii</scp>)–cymene complexes containing curcumin and bisdemethoxycurcumin ligands. Inorganic Chemistry Frontiers, 2019, 6, 2448-2457. 6.3 14 74 Ruthenium arene complexes with mono-carbonyl analogues of curcumin as pendant or bridging ligands: Synthesis, anti-cancer activity and interaction with quadruplex DNA. Polyhedron, 2019, 171, 396-402. 2.4 9 75 Zn(II) Curcuminate Complexes with 2,2′-bipyridine and Carboxylates. Molecules, 2019, 24, 2540. 4.2 19 5 0 1 Citation Report # Article IF Citations 76 Hydroxyquinoline-derived anticancer organometallics: Introduction of amphiphilic PTA as an ancillary ligand increases their aqueous solubility. Journal of Inorganic Biochemistry, 2019, 199, 110768. 3.0 44 77 Photocytotoxic Activity of Copper(II) and Zinc(II) Complexes of Curcumin and (Acridinyl)dipyridophenazine. ChemistrySelect, 2019, 4, 9647-9658. 1.7 16 78 Eighteen 5,7-Dihalo-8-quinolinol and 2,2′-Bipyridine Co(II) Complexes as a New Class of Promising Anticancer Agents. ACS Medicinal Chemistry Letters, 2019, 10, 1603-1608. 3.3 34 79 Strong inÂvitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives. European Journal of Medicinal Chemistry, 2019, 184, 111751. 5.3 71 80 Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies. RSC Advances, 2019, 9, 3239-3278. 4.4 80 81 Development of Natural Product-Conjugated Metal Complexes as Cancer Therapies. International Journal of Molecular Sciences, 2019, 20, 341. 4.4 43 82 High in Vitro and in Vivo Tumor-Selective Novel Ruthenium(II) Complexes with 3-(2′-Benzimidazolyl)-7-fluoro-coumarin. ACS Medicinal Chemistry Letters, 2019, 10, 936-940. 3.3 57 83 Rationally designed curcumin based ruthenium(<scp>ii</scp>) antimicrobials effective against drug-resistant <i>Staphylococcus aureus</i>. Dalton Transactions, 2019, 48, 11822-11828. 3.0 46 84 Non-platinum complexes containing releasable biologically active ligands. Coordination Chemistry Reviews, 2019, 395, 130-145. 23.1 99 85 Comparable investigation of in vitro interactions between three ruthenium(II) arene complexes with curcumin analogs and ctDNA. Polyhedron, 2019, 167, 51-61. 2.4 8 86 Vibrational signatures of curcumin’s chelation in copper(II) complexes: An appraisal by IRMPD spectroscopy. Journal of Chemical Physics, 2019, 150, . 2.8 11 87 Novel half-sandwich rhodium(III) and iridium(III) photosensitizers for dual chemo- and photodynamic therapy. Photodiagnosis and Photodynamic Therapy, 2019, 26, 448-454. 2.2 15 88 Design of organoruthenium complexes for nanoparticle functionalization. Journal of Organometallic Chemistry, 2019, 891, 64-71. 2.1 0 89 Photocytotoxic cancer cell-targeting platinum(<scp>ii</scp>) complexes of glucose-appended curcumin and biotinylated 1,10-phenanthroline. Dalton Transactions, 2019, 48, 17556-17565. 3.0 37 90 Synthesis and antimicrobial studies of half-sandwich arene platinum group complexes containing pyridylpyrazolyl ligands. Journal of Coordination Chemistry, 2019, 72, 294-308. 2.6 16 91 Antifibrotic and tumor microenvironment modulating effect of date palm fruit (Phoenix dactylifera) Tj ETQq1 1 0.784314 rgBT 6.7 39/Overlock 92 Conjugating Biotin to Ruthenium(II) Arene Units via Phosphine Ligand Functionalization. European Journal of Inorganic Chemistry, 2020, 2020, 1061-1072. 1.8 11 93 Use of anethole-type ligands to design cytotoxic organometallic ruthenium compounds: An experimental and computational study. Journal of Organometallic Chemistry, 2020, 908, 121094. 2.1 2 6 Citation Report # Article IF Citations 94 Encapsulation of a Ru(η⁶-<i>p</i>-cymene) complex of the antibacterial drug trimethoprim into a polydiacetylene-phospholipid assembly to enhance its <i>in vitro</i> anticancer and antibacterial activities. New Journal of Chemistry, 2020, 44, 20047-20059. 2.4 22 95 Synthesis, characterization and photodynamic activity of half-sandwich rhodium(III) complexes with curcuminoids. Photodiagnosis and Photodynamic Therapy, 2020, 32, 102049. 2.2 6 96 Investigating the reactivity of neutral water-soluble Ru(<scp>ii</scp>)–PTA carbonyls towards the model imine ligands pyridine and 2,2′-bipyridine. RSC Advances, 2020, 10, 26717-26727. 4.4 3 97 &lt;p&gt;Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives&lt;/p&gt;. Drug Design, Development and Therapy, 2020, Volume 14, 5375-5392. 6.9 349 98 Cp and indenyl ruthenium complexes containing dithione derivatives: Synthesis, antibacterial and antifungal study. Journal of Organometallic Chemistry, 2020, 923, 121418. 2.1 4 99 Synthesis and anti-cancer activity of bis-amino-phosphine ligand and its ruthenium(II) complexes. Bioorganic and Medicinal Chemistry Letters, 2020, 30, 127492. 2.0 16 100 Novel Zn(II) Coordination Polymers Based on the Natural Molecule Bisdemethoxycurcumin. Crystal Growth and Design, 2020, 20, 6555-6564. 3.4 6 101 Curcumin Innovative Delivery Forms: Paving the ‘Yellow Brick Road’ of Antitumoral Phytotherapy. Applied Sciences (Switzerland), 2020, 10, 8990. 2.1 13 102 Bifunctional ruthenium(<scp>ii</scp>) polypyridyl complexes of curcumin as potential anticancer agents. Dalton Transactions, 2020, 49, 9454-9463. 3.0 37 103 New Tailored RNA-Targeted Organometallic Drug Candidates against Huh7 (Liver) and Du145 (Prostate) Cancer Cell Lines. ACS Omega, 2020, 5, 15218-15228. 4.3 22 104 Novel ruthenium and palladium complexes as potential anticancer molecules on SCLC and NSCLC cell lines. Chemical Papers, 2020, 74, 2883-2892. 2.2 16 105 Synthesis, Characterization, Cytotoxic Activity, and Metabolic Studies of Ruthenium(II) Polypyridyl Complexes Containing Flavonoid Ligands. Inorganic Chemistry, 2020, 59, 4424-4434. 4.6 49 106 Imaging and therapeutic applications of Zn(<scp>ii</scp>)-cryptolepine–curcumin molecular probes in cell apoptosis detection and photodynamic therapy. Chemical Communications, 2020, 56, 3999-4002. 3.4 54 107 A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status. Journal of Experimental and Clinical Cancer Research, 2020, 39, . 11.3 30 108 Nuclear factor erythroid 2 (NF―E2) p45―related factor 2 interferes with homeodomain―interacting protein kinase 2/p53 activity to impair solid tumors chemosensitivity. IUBMB Life, 2020, 72, 1634-1639. 2.9 10 109 Tethering (Arene)Ru(II) Acylpyrazolones Decorated with Long Aliphatic Chains to Polystyrene Surfaces Provides Potent Antibacterial Plastics. Materials, 2020, 13, 526. 2.9 8 110 Protein binding studies with human serum albumin, molecular docking and<i>in vitro</i>cytotoxicity studies using HeLa cervical carcinoma cells of Cu(<scp>ii</scp>)/Zn(<scp>ii</scp>) complexes containing a carbohydrazone ligand. Dalton Transactions, 2020, 49, 2947-2965. 3.0 48 111 Ruthenium(II)-arene complexes containing ferrocenamide ligands: Synthesis, characterisation and antiproliferative activity against cancer cell lines. Journal of Organometallic Chemistry, 2020, 916, 121247. 2.1 11 7 Citation Report # Article IF Citations 112 Synthesis of half sandwich platinum group metal complexes containing pyridyl benzothiazole hydrazones: Study of bonding modes and antimicrobial activity. Journal of Organometallic Chemistry, 2020, 914, 121225. 2.1 21 4.8 22 1.8 0 3.0 14 Drive to organoruthenium and organoiridium complexes from organoplatinum: Next-generation anticancer metallotherapeutics. Inorganic Chemistry Communication, 2021, 124, 108364. Stereoisomeric Control in [RuCl 2 (PTA) 2 (2L)] Complexes (2L=2py or bpy): From Theoretical Calculations to a 2+2 Metallacycle of Pyridylporphyrins. European Journal of Inorganic Chemistry, 2021, 2021, 321-334. <i>N</i>,<i>N</i>-Ru(<scp>ii</scp>)-<i>p</i>-cymene-poly(<i>N</i>-vinylpyrrolidone) surface functionalized gold nanoparticles: from organoruthenium complex to nanomaterial for antiproliferative activity. Dalton Transactions, 2021, 50, 8232-8242. 113 114 115 116 Mitochondria-localizing curcumin-cryptolepine Zn(II) complexes and their antitumor activity. Bioorganic and Medicinal Chemistry, 2021, 30, 115948. 2.6 23 117 Specific Loading and In Vitro Controlled Release of a Ru-Based Hydrophobically Encapsulated Model Anticancer Drug inside Nanoassemblies toward Stimuli-Responsive Drug Delivery. ACS Applied Nano Materials, 2021, 4, 2037-2051. 5.3 15 118 Biotin―Appended Iron(III) Complexes of Curcumin for Targeted Photo―Chemotherapy. European Journal of Inorganic Chemistry, 2021, 2021, 1640-1650. 1.8 13 119 Piano-Stool Ruthenium(II) Complexes with Delayed Cytotoxic Activity: Origin of the Lag Time. Inorganic Chemistry, 2021, 60, 7974-7990. 4.6 30 120 Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activity. Journal of Inorganic Biochemistry, 2021, 218, 111387. 3.0 6 121 Lead (Pb) exposure induces physiological alterations in the serotoninergic and vasopressin systems causing anxiogenic-like behavior in Meriones shawi: Assessment of BDMC as a neuroprotective compound for Pb-neurotoxicity and kidney damages. Journal of Trace Elements in Medicine and Biology, 2021, 65, 126722. 3.0 19 122 Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells. Cancers, 2021, 13, 2493. 3.8 26 123 Ruthenium (II)―Coordinated Supramolecular Metallodrug Complex Realizing Oxygen Self―Supply In Situ for Overcoming Hypoxic Tumors. Advanced Functional Materials, 2021, 31, . 17.0 31 124 Arene ruthenium, rhodium and iridium complexes containing N∩O chelating ligands: synthesis, antibacterial and antioxidant studies. Journal of Coordination Chemistry, 2021, 74, 2365-2379. 2.6 9 125 Biological Investigations of Ru(II) Complexes with Diverse β―Diketone Ligands. European Journal of Inorganic Chemistry, 2021, 2021, 3611-3621. 1.8 12 126 Photoactivated Osmium Arene Anticancer Complexes. Inorganic Chemistry, 2021, 60, 17450-17461. 4.6 39 127 Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer. Pharmaceutics, 2021, 13, 1559. 4.9 5 128 Modulation of catalytic and biomolecular binding properties of ruthenium(II)-arene complexes with the variation of coligands for selective toxicity against cancerous cells. Polyhedron, 2021, 207, 115379. 2.4 20 129 Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands. Coordination Chemistry Reviews, 2021, 445, 213950. 23.1 83 8 Citation Report # Article IF Citations 130 Synthesis, structure, spectral, redox properties and anti-cancer activity of Ruthenium(II) Arene complexes with substituted Triazole Ligands. Journal of Organometallic Chemistry, 2021, 954-955, 122074. 2.1 10 131 Relativistic Quantum Chemical and Molecular Dynamics Techniques for Medicinal Chemistry of Bioinorganic Compounds. Topics in Medicinal Chemistry, 2021, , 133-193. 0.0 20 132 Acid-assisted hydrogenation of CO₂ to methanol using Ru(<scp>ii</scp>) and Rh(<scp>iii</scp>) RAPTA-type catalysts under mild conditions. Chemical Communications, 2021, 57, 8941-8944. 3.4 12 133 Variable structural bonding modes and antibacterial studies of thiosemicarbazone ligands of ruthenium, rhodium, and iridium metal complexes. Journal of Coordination Chemistry, 2020, 73, 175-187. 2.6 6 134 Enhanced anticancer property of bio―organometallic nano composites: Design, characterization, and biological evaluation. Applied Organometallic Chemistry, 2022, 36, . 3.8 5 135 Mononuclear Mn complexes featuring N,S-/N,N-donor and 1,3,5-triaza-7-phosphaadamantane ligands: synthesis and electrocatalytic properties. New Journal of Chemistry, 2021, 45, 20272-20279. 2.4 3 136 Complexes of Zn(<scp>ii</scp>) with a mixed tryptanthrin derivative and curcumin chelating ligands as new promising anticancer agents. Dalton Transactions, 2022, 51, 5024-5033. 3.0 24 137 Systematic Study on the Cytotoxic Potency of Commonly Used Dimeric Metal Precursors in Human Cancer Cell Lines. ChemistryOpen, 2022, 11, . 2.6 10 138 A Computational approach toward organometallic ruthenium(II) compounds with tunable hydrolytic properties. Chemical Physics, 2022, 560, 111587. 2.2 1 139 Nanoencapsulation of Ru(<i>p</i>-cymene) Complex Bearing Ginger-based Natural Product into Liposomal Nanoformulation to Improve Its Cellular Uptake and Antiproliferative Activity. ACS Applied Bio Materials, 2022, 5, 3241-3256. 4.7 20 140 Design, Synthesis, and Anticancer Studies of a <i>p</i>-Cymene-Ru(II)-Curcumin Organometallic Conjugate Based on a Fluorescent 4-Amino-1,8-naphthalimide Tröger’s Base Scaffold. Inorganic Chemistry, 2022, 61, 11592-11599. 4.6 25 141 Anticancer pH-Responsive Supramolecular Vesicles Fabricated Using Water-Soluble Pillar[5]arene and Curcumin Derivative. Materials and Design, 2022, 222, 111084. 6.9 14 143 Potent and selective anticancer activity of half-sandwich ruthenium and osmium complexes with modified curcuminoid ligands. Dalton Transactions, 2022, 51, 13311-13321. 3.0 20 144 A photoactive lysosome targeting Ru^II complex downregulates stemness genes in oral squamous cell carcinoma. Inorganic Chemistry Frontiers, 2022, 9, 5840-5852. 6.3 8 145 Transition metallo-curcumin complexes: a new hope for endometriosis?. Journal of Materials Chemistry B, 2022, 10, 9682-9698. 5.5 5 146 Anticancer evaluation of new organometallic ruthenium(<scp>ii</scp>) flavone complexes. RSC Medicinal Chemistry, 2023, 14, 253-267. 3.2 20 147 Antioxidant conjugated metal complexes and their medicinal applications. Vitamins and Hormones, 2023, , 319-353. 2.9 0 148 Ionic mononuclear [Fe] and heterodinuclear [Fe,Ru] bis(diphenylphosphino)alkane complexes: Synthesis, spectroscopy, DFT structures, cytotoxicity, and biomolecular interactions. Journal of Inorganic Biochemistry, 2023, 242, 112156. 3.0 7 9 Citation Report # Article IF Citations 149 An overview of advancement of organoruthenium(II) complexes as prospective anticancer agents. Coordination Chemistry Reviews, 2023, 487, 215169. 23.1 66 150 NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells. Biomedicines, 2023, 11, 593. 3.4 9 151 Metal Complexes in Cancer Treatment: Journey So Far. Chemistry and Biodiversity, 2023, 20, . 2.2 58 152 “Half-Sandwich― Ruthenium Complexes with Alizarin as Anticancer Agents: <i>In Vitro</i> and <i>In Vivo</i> Studies. Inorganic Chemistry, 2023, 62, 6955-6969. 4.6 19 153 Therapeutic potential and limitations of curcumin as antimetastatic agent. Biomedicine and Pharmacotherapy, 2023, 163, 114758. 6.7 50 154 Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C. European Journal of Medicinal Chemistry, 2023, 258, 115536. 5.3 10 155 Nanogels, nanodiscs, yeast cells, and metallo-complexes-based curcumin delivery for therapeutic applications. European Polymer Journal, 2023, 196, 112215. 5.9 16 156 Ruthenium complexes of 1,4-diazabutadiene ligands with a <i>cis</i>-RuCl₂ moiety for catalytic acceptorless dehydrogenation of alcohols: DFT evidence of chemically non-innocent ligand participation. RSC Advances, 2023, 13, 25660-25672. 4.4 8 157 Novel azo metal chelates of 3-aminophthalhydrazide derivative: Structural investigation, evaluation of DNA cleavage, anticancer and molecular docking studies. Inorganic Chemistry Communication, 2023, 158, 111535. 4.8 0 158 Interaction of gallium, indium, and vanadyl curcumin complexes with hen egg-white lysozyme (HEWL): Mechanistic aspects and evaluation of antiamyloidogenic activity. Biochemical and Biophysical Research Communications, 2024, 691, 149307. 2.1 0 159 Antimicrobial study of ruthenium and iridium half-sandwich complexes containing fluorenyl hydrazonothiazole derivative ligands. Journal of Coordination Chemistry, 2023, 76, 1650-1665. 2.6 1 160 NRF2 activation in BON‑1 neuroendocrine cancerÂcells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study. Oncology Reports, 2024, 51, . 2.8 3 161 Unraveling the Anticancer Efficacy and Biomolecular Properties of Ru(II)-Arene Complexes of Pyrene-Based Thiosemicarbazone Ligands: A Comprehensive <i>In Silico</i>/<i>In Vitro</i> Exploration. Organometallics, 2024, 43, 242-260. 2.9 14 162 Biological evaluation of ruthenium(II) complexes appended curcumin derivatives: Synthesis, spectral characterization, anti-oxidant and anti-cancer studies. Inorganica Chimica Acta, 2024, 565, 121997. 2.8 5 163 New Ru(II)-p-cymene compounds bearing indomethacin and indomethacin-pyridineamide ligands: synthesis, characterization, computational studies and investigation of their interactions with the Human Serum Albumin. Inorganica Chimica Acta, 2024, 567, 122060. 2.8 1 164 Development of Half-Sandwich Ru, Os, Rh, and Ir Complexes Bearing the Pyridine-2-ylmethanimine Bidentate Ligand Derived from 7-Chloroquinazolin-4(3H)-one with Enhanced Antiproliferative Activity. ACS Omega, 2024, 9, 18224-18237. 4.3 4 165 Ru(II)-Arene Complexes of Curcumin and Bisdesmethoxycurcumin Metabolites. Inorganic Chemistry, 2024, 63, 7955-7965. 4.6 9 166 Organoruthenium metallocycle induced mutation in gld-1 tumor suppression gene in JK1466 strain and appreciable lifespan expansion. Journal of Inorganic Biochemistry, 2024, 257, 112593. 3.0 4 10 Citation Report # Article IF Citations 167 A mini-review on Ru(II)-curcumin metal complexes based anticancer agents. Inorganica Chimica Acta, 2024, 569, 122156. 2.8 6 168 Pd(<scp>ii</scp>)/diphosphine/curcumin complexes as potential anticancer agents. Dalton Transactions, 2024, 53, 18902-18916. 3.0 6 169 Ruthenium(II) complexes of curcumin and β-diketone derivatives: effect of structural modifications on their cytotoxicity. Royal Society Open Science, 2024, 11, . 2.4 2 170 Biomolecular Interactions and Anticancer Mechanisms of Ru(II)-Arene Complexes of Cinnamaldehyde-Derived Thiosemicarbazone Ligands: Analysis Combining In Silico and In Vitro Approaches. ACS Applied Bio Materials, 2024, 7, 5622-5639. 4.7 12 171 Recent advances in Rh(III)-based anticancer complexes. Coordination Chemistry Reviews, 2025, 525, 216306. 23.1 11 172 Positively-charged, chalcone-hydroxypyrone hybrid ruthenium(II)-arene complexes functionalized with ethacrynic acid: Synthesis, characterizaion, and antitumor effect. Journal of Inorganic Biochemistry, 2025, 263, 112778. 3.0 0 173 Exploring the effect of Ru(<scp>ii</scp>) arene complexes on cytotoxicity upon co-ligand variation and loading on amine-functionalized silica nanoparticles. Dalton Transactions, 2025, 54, 7449-7457. 3.0 4 174 Ruthenium (II)-coordinated supramolecular drug self-assembly for efficient combination chemotherapy. Supramolecular Materials, 2025, 4, 100113. 4.0 1 175 Ruthenium(<scp>ii</scp>)-bisdemethoxycurcumin conjugate complexes as potent antitumour agents through simultaneous inhibition of 20S proteasome and HMG-CoA reductase. Dalton Transactions, 2025, 54, 11324-11336. 3.0 2 176 Exploring the toxicity of mononuclear piano-stool Ru(II) anticancer agents: A comprehensive literature review. Coordination Chemistry Reviews, 2025, 543, 216902. 23.1 4 177 Understanding the Modes of Action of β-Ketoiminato Iridium(III) Complexes in Cancer Cells. Inorganic Chemistry, 0, 64, 17189-17199. 4.6 1 179 Fluorescent probe materials based on curcumin derivatives for anti-tumor studies: A review. Results in Chemistry, 0, 18, 102831. 3.5 0 180 Computational insights into Ru() Tj ETQq0 0 0 rgBT /Overlock 10 Tf 50 272 Td ( <scp>ii</scp>) Tj ETQq0 0 0 rgBT /Overlock 1 2.7 0 docking and molecular dynamics approach. Physical Chemistry Chemical Physics, 0, 28, 1447-1462. 181 Photodynamic therapeutic potential and challenges of platinum group metal complexes in cancer treatment. Journal of Coordination Chemistry, 0, , 1-36. 2.6 0 182 Comparative study of half-sandwich (η6-arene)RuClâ‚‚(P(OMe)₃) (p-cymene, C6Me6) towards AgOTf and the influence of coordinated solvents in the chemistry of p-cymene derivatives. Journal of Organometallic Chemistry, 0, , 124069. 2.1 0 11